Efficient treatment of breast cancer xenografts with multifunctionalized iron oxide nanoparticles combining magnetic hyperthermia and anti-cancer drug delivery
Open Access
- 13 May 2015
- journal article
- research article
- Published by Springer Science and Business Media LLC in Breast Cancer Research
- Vol. 17 (1), 1-17
- https://doi.org/10.1186/s13058-015-0576-1
Abstract
Tumor cells can effectively be killed by heat, e.g. by using magnetic hyperthermia. The main challenge in the field, however, is the generation of therapeutic temperatures selectively in the whole tumor region. We aimed to improve magnetic hyperthermia of breast cancer by using innovative nanoparticles which display a high heating potential and are functionalized with a cell internalization and a chemotherapeutic agent to increase cell death. The superparamagnetic iron oxide nanoparticles (MF66) were electrostatically functionalized with either Nucant multivalent pseudopeptide (N6L; MF66-N6L), doxorubicin (DOX; MF66-DOX) or both (MF66-N6LDOX). Their cytotoxic potential was assessed in a breast adenocarcinoma cell line MDA-MB-231. Therapeutic efficacy was analyzed on subcutaneous MDA-MB-231 tumor bearing female athymic nude mice. All nanoparticle variants showed an excellent heating potential around 500 W/g Fe in the alternating magnetic field (AMF, conditions: H = 15.4 kA/m, f = 435 kHz). We could show a gradual inter- and intracellular release of the ligands, and nanoparticle uptake in cells was increased by the N6L functionalization. MF66-DOX and MF66-N6LDOX in combination with hyperthermia were more cytotoxic to breast cancer cells than the respective free ligands. We observed a substantial tumor growth inhibition (to 40% of the initial tumor volume, complete tumor regression in many cases) after intratumoral injection of the nanoparticles in vivo. The proliferative activity of the remaining tumor tissue was distinctly reduced. The therapeutic effects of breast cancer magnetic hyperthermia could be strongly enhanced by the combination of MF66 functionalized with N6L and DOX and magnetic hyperthermia. Our approach combines two ways of tumor cell killing (magnetic hyperthermia and chemotherapy) and represents a straightforward strategy for translation into the clinical practice when injecting nanoparticles intratumorally.Keywords
This publication has 39 references indexed in Scilit:
- Intravenous magnetic nanoparticle cancer hyperthermiaInternational Journal of Nanomedicine, 2013
- Design Maps for the Hyperthermic Treatment of Tumors with Superparamagnetic NanoparticlesPLOS ONE, 2013
- Effect of magnetic fluid hyperthermia on lung cancer nodules in a murine modelOncology Letters, 2011
- Targeting surface nucleolin with multivalent HB-19 and related Nucant pseudopeptides results in distinct inhibitory mechanisms depending on the malignant tumor cell typeBMC Cancer, 2011
- Aptamer-functionalized PEG–PLGA nanoparticles for enhanced anti-glioma drug deliveryBiomaterials, 2011
- A Simple Approach to Cancer Therapy Afforded by Multivalent Pseudopeptides That Target Cell-Surface NucleoproteinsCancer Research, 2011
- Functionalization of Iron Oxide Magnetic Nanoparticles with Targeting Ligands: Their Physicochemical Properties and In Vivo BehaviorNanomedicine, 2010
- Pharmacokinetic parameters and tissue distribution of magnetic Fe3O4 nanoparticles in miceInternational Journal of Nanomedicine, 2010
- Comparative effects of thermosensitive doxorubicin-containing liposomes and hyperthermia in human and murine tumoursInternational Journal of Hyperthermia, 2010
- Suppression of Tumor Growth and Angiogenesis by a Specific Antagonist of the Cell-Surface Expressed NucleolinPLOS ONE, 2008